SoviHep V: Improving the Management of Hepatitis C: SoviHep V, which consists of 100 mg of Velpatasvir and 400 mg of Sofosbuvir, is a new treatment for Hepatitis C. This new antiviral drug significantly lowers the viral load by blocking the growth of HCV by specifically targeting a particular protein. For patients with chronic Hepatitis C, SoviHep V provides an original therapy option with its broad-spectrum efficacy against genotypes 1–6.
Address - 1E/20, 3rd Floor, Jhandewalan Extension New Delhi -110055
Contact Us - +91 98116 04444, +919999064250
Email -
[email protected]
More Info - https://www.gandhimedicos.in/product/sovihep-v/
